Myriad Genetics, Inc. MYGN
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 107.10M | 115.20M | 124.40M | 149.60M | 145.40M |
| Total Receivables | 105.50M | 109.50M | 123.80M | 115.30M | 118.00M |
| Inventory | 28.60M | 30.60M | 27.90M | 30.60M | 31.60M |
| Prepaid Expenses | 30.70M | 33.70M | 36.70M | 35.40M | 49.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 1.70M | -- |
| Total Current Assets | 271.90M | 289.00M | 312.80M | 332.60M | 344.80M |
|
|
|||||
| Total Current Assets | 271.90M | 289.00M | 312.80M | 332.60M | 344.80M |
| Net Property, Plant & Equipment | 153.60M | 158.90M | 162.50M | 163.40M | 162.00M |
| Long-term Investments | 47.10M | 47.10M | 47.10M | 51.60M | 51.60M |
| Goodwill | 47.10M | 47.10M | 47.10M | 51.60M | 51.60M |
| Total Other Intangibles | 131.80M | 139.00M | 145.70M | 153.40M | 163.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.80M | 4.90M | 5.60M | 5.60M | 6.60M |
| Total Assets | 609.20M | 638.90M | 673.70M | 706.60M | 728.10M |
|
|
|||||
| Total Accounts Payable | 27.60M | 30.40M | 32.60M | 30.00M | 31.80M |
| Total Accrued Expenses | 71.30M | 64.70M | 64.60M | 71.30M | 77.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.80M | 7.30M | 7.10M | 6.90M | 7.90M |
| Total Finance Division Other Current Liabilities | 30.90M | 28.30M | 25.90M | 25.60M | 31.10M |
| Total Other Current Liabilities | 30.90M | 28.30M | 25.90M | 25.60M | 31.10M |
| Total Current Liabilities | 137.60M | 130.70M | 130.20M | 133.80M | 148.00M |
|
|
|||||
| Total Current Liabilities | 137.60M | 130.70M | 130.20M | 133.80M | 148.00M |
| Long-Term Debt | 121.10M | 120.70M | 120.30M | 119.90M | 119.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 80.50M | 82.50M | 84.10M | 83.00M | 84.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.00M | 1.10M | 1.70M | 1.90M | 2.90M |
| Total Liabilities | 340.20M | 335.00M | 336.30M | 338.60M | 355.30M |
|
|
|||||
| Common Stock & APIC | 1.51B | 1.50B | 1.49B | 1.49B | 1.49B |
| Retained Earnings | -1.24B | -1.20B | -1.16B | -1.12B | -1.11B |
| Treasury Stock & Other | 700.00K | 800.00K | 700.00K | 800.00K | -100.00K |
| Total Common Equity | 269.00M | 303.90M | 337.40M | 368.00M | 372.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 269.00M | 303.90M | 337.40M | 368.00M | 372.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 269.00M | 303.90M | 337.40M | 368.00M | 372.80M |
|
|
|||||